Clinical Trial Update: Comparative Pharmacokinetics and Pharmacodynamics of Peginterferon BIP48 and 40kDa in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial comparing pharmacokinetics and pharmacodynamics of two pegylated interferon formulations (BIP48 and a 40 kDa peginterferon) in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Hepatitis

Drugs mentioned

• peginterferon 40 kDa (peginterferon 40 kDa)
• peginterferon BIP48 (peginterferon BIP48)

Snippet

Sponsor: The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | Conditions: Chronic Viral Hepatitis C | Phase 1 | Status: COMPLETED